Comparison of the long-term efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naïve HBeAg-positive patients with chronic hepatitis B: A large, multicentre, randomized controlled trials

OBJECTIVE: We conducted this study to compare the efficacy and safety of entecavir and tenofovir in the treatment of treatment-naïve HBV e antigen (HBeAg)-positive patients with chronic hepatitis B (CHB) for 144 weeks. METHODS: A total of 320 treatment-naïve HBeAg-positive CHB patients who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Dachuan, Pan, Chen, Yu, Weihua, Dang, Shuangsuo, Li, Jia, Wu, Shanming, Jiang, Nan, Wang, Maorong, Zhang, Zhaohua, Lin, Feng, Xin, Shaojie, Yang, Yongfeng, Shen, Baoshen, Ren, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344155/
https://www.ncbi.nlm.nih.gov/pubmed/30608440
http://dx.doi.org/10.1097/MD.0000000000013983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344155/
https://www.ncbi.nlm.nih.gov/pubmed/30608440
http://dx.doi.org/10.1097/MD.0000000000013983

Ejemplares similares